(This is an abridged version of a story that appears in the July issue of Marijuana Business Magazine.)
The American marijuana industry is in a far better place for businesses seeking to raise money than it was a year ago.
In fact, the landscape has grown leaps and bounds from three or four years ago, when there were fewer than 20 medical cannabis markets in the U.S., and Colorado and Washington were the only states with recreational cannabis companies.
That was a time when marijuana businesses had little capital available to them, and investors were outliers on the risk-tolerance chart.
“The risk factors three and five years ago were so much greater, and the types of people investing were different,” said Sheri Orlowitz, who founded Artemis Capital, a marijuana-focused private equity firm in Washington DC, after serving as a prosecutor for the U.S. Department of Justice
“A few years ago, you were talking about real gamblers, penny stock people. It was a whole different risk tolerance and personality back then.
“Today, you have far less risk. There is a ton more legitimate money out there now.”
Family offices and people of high net worth continue to invest heavily in marijuana businesses, but a broader spectrum of investors are now seriously looking at the cannabis industry, ranging from private equity firms to angels to venture capital.
The investment climate has changed so much so fast that Marijuana Business Magazine took a deep dive into the topic, seeking insights from cannabis entrepreneurs involved in successful raises, other industry insiders and investors about raising MJ money in 2019 and the future.
Some of the lessons learned include:
Meanwhile, some finance veterans who have transitioned to the cannabis sector share their insights on how American cannabis companies can find funding:
Finally, more and more U.S. firms are turning to Canada to raise money. Here’s a look at how that move could work.
Written by Omar Sacirbey
Marijuana Business Daily